---
title: "百心安控股股東計劃增持  資金上限 1,500 萬元"
description: "百心安－B 公佈，控股股東汪立計劃即日起約十二個月內，通過其全資擁有的 Winning Powerful 在公開市場增持公司 H 股，預計總金額不超過 1,500 萬元。目前，Winning Powerful 持有 4,564.55 萬股 H 股，約佔公司股本 18.75%。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/261914197.md"
published_at: "2025-10-20T14:44:38.000Z"
---

# 百心安控股股東計劃增持  資金上限 1,500 萬元

> 百心安－B 公佈，控股股東汪立計劃即日起約十二個月內，通過其全資擁有的 Winning Powerful 在公開市場增持公司 H 股，預計總金額不超過 1,500 萬元。目前，Winning Powerful 持有 4,564.55 萬股 H 股，約佔公司股本 18.75%。

百心安－B(02185.HK) 公佈，控股股東汪立計劃即日起約十二個月內，通過其全資擁有的 Winning Powerful 在公開市場增持公司 H 股，預計總金額不超過 1,500 萬元。目前，Winning Powerful 持有 4,564.55 萬股 H 股，約佔公司股本 18.75%。

### Related Stocks

- [02185.HK - 百心安-B](https://longbridge.com/zh-HK/quote/02185.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| CICC Reaffirms Their Buy Rating on Suzhou Ribo Life Science Co., Ltd. Class H (6938) | In a report released yesterday, from CICC maintained a Buy rating on Suzhou Ribo Life Science Co., Ltd. Class H, with a  | [Link](https://longbridge.com/zh-HK/news/276199846.md) |
| Smart Eye Q4 EBITDA Up At Sek 10.2 Million | Smart Eye AB (publ) :Q4 EBITDA SEK 10.2 MILLIONQ4 NET INCOME SEK -49.5 MILLIONQ4 SALES SEK 122.3 MILLIONBOARD OF DIRECTO | [Link](https://longbridge.com/zh-HK/news/276097619.md) |
| Guotai Haitong Sticks to Its Buy Rating for Shenzhen Edge Medical Co., Ltd. Class H (2675) | Guotai Haitong analyst maintained a Buy rating on Shenzhen Edge Medical Co., Ltd. Class H yesterday and set a price targ | [Link](https://longbridge.com/zh-HK/news/275997117.md) |
| 23:43 ETDie innovativen Sicherheits- und hocheffizienten Antriebsstränge von GAC finden weltweite Anerkennung | GAC is gaining global recognition for its innovative and efficient drivetrains amidst the rapidly changing automotive in | [Link](https://longbridge.com/zh-HK/news/275994919.md) |
| Berkshire Hathaway discloses investment in New York Times | Berkshire Hathaway has disclosed a new investment in the New York Times, reentering a sector it left in 2020. The compan | [Link](https://longbridge.com/zh-HK/news/276173033.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。